Navigation Links
Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets
Date:9/23/2010

nditions. Advances in these devices and their implantation techniques can improve the cost benefit of treatment of spinal conditions.

The objectives of this report are to present a comprehensive analysis of the market for these orthopedic products and forecast their commercial potential through 2015. 

This report will:Assess the prevalence of common spinal conditions and trends affecting their projected future incidence

Examine current procedure volumes and associated expenditures, as well as projected increases in demand by technique

Analyze the current market and forecast demand for implantable spinal surgical devices

Describe the regulatory framework and its effect on the introduction of new devices into the spinal market both in the U.S. and abroad

Analyze trends in patent applications and issued patents for innovations that will be altering the spinal marketplace

Examine the drivers that will affect future utilization and rate of adoption of the implants, including demographic changes, reimbursement policy, clinical considerations, and R&D 

Identify the product manufacturers that will drive innovation, their market share, and other industry players

REASONS FOR DOING THE STUDYThe world's population is aging at an unprecedented rate. Aging populations face increased rates of arthritic and degenerative conditions. This trend is particularly pronounced upon examination of the prevalence of back pain and underlying spinal conditions. 

The convergence of the following trends represents the motivation for this report:The worldwide growth of the senior population will strain the capabilities of healthcare providers and the financial resources of healthcare payers.

Patients are increasingly less likely to accept "aging pains" as they wish to maintain a more active lifestyle even with advancing age.

Obesity, which is also increasing globally, wil
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Reportlinker Adds Actelion Ltd: PharmaVitae Profile
2. Reportlinker Adds Pfizer Inc.: PharmaVitae Profile
3. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
4. Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile
5. Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012
6. Reportlinker Adds The Impact of US Healthcare Reform on Pharma: Analyzing the Effects
7. Reportlinker Adds IP Overview - "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010
8. Reportlinker Adds Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
9. Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
10. Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010
11. Reportlinker Adds Canadian Dental Market Overview & Dentist Survey 2010 (Implants, Prosthetics, Imaging & CAD/CAM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... and PITTSBURGH , Aug. ... ) today announced that its shareholders have approved ... PRGO ; TASE) and the related issuance ... an extraordinary general meeting of shareholders held today. ... cast at the extraordinary general meeting. In addition, ...
(Date:8/28/2015)... -- The report "Eubiotics Market by Type (Probiotics, Prebiotics, Organic ... & by Region ( North America , ... Rest of the World) - Global Trends and Forecast to ... valued at USD 4.62 Billion in 2014 and is projected ... of 7.4% from 2015 to 2020. Browse ...
(Date:8/28/2015)... Massachusetts and LONDON , August ... approach seamlessly connects ... continuum improving outcomes and the ...  (NYSE: PHG AEX: PHIA) today announced its presence at  ... latest cardiology solutions, including Heart Model A.I. , EchoNavigator and ...
Breaking Medicine Technology:Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4
... Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that ... received preferred Tier 2 formulary status with all ... benefits manager, Prescription Solutions ® .  The AARP ... MedicareComplete from Secure Horizons, provide prescription drug access ...
... Omeros Corporation (NASDAQ: OMER ) ... its product candidates from its PharmacoSurgery™ platform – ... lens replacement surgery – into Phase 3 clinical ... added to standard irrigation solutions and delivered intra-operatively ...
Cached Medicine Technology:Pradaxa® (dabigatran etexilate mesylate) Capsules Gains Preferred Formulary Status with AARP®, Nation's Largest Provider of Medicare Part D Coverage 2Pradaxa® (dabigatran etexilate mesylate) Capsules Gains Preferred Formulary Status with AARP®, Nation's Largest Provider of Medicare Part D Coverage 3Pradaxa® (dabigatran etexilate mesylate) Capsules Gains Preferred Formulary Status with AARP®, Nation's Largest Provider of Medicare Part D Coverage 4Pradaxa® (dabigatran etexilate mesylate) Capsules Gains Preferred Formulary Status with AARP®, Nation's Largest Provider of Medicare Part D Coverage 5Pradaxa® (dabigatran etexilate mesylate) Capsules Gains Preferred Formulary Status with AARP®, Nation's Largest Provider of Medicare Part D Coverage 6Omeros Announces Clinical Development Programs for OMS103HP and OMS302 2Omeros Announces Clinical Development Programs for OMS103HP and OMS302 3Omeros Announces Clinical Development Programs for OMS103HP and OMS302 4Omeros Announces Clinical Development Programs for OMS103HP and OMS302 5
(Date:8/28/2015)... ... August 28, 2015 , ... For Dallas, the time is nearing for ... subsidiary USPI Tenet Health. , The American Heart Association hosts their well-known Heart Walk ... believe that together, a difference can be made. Walkers can participate in the cause ...
(Date:8/28/2015)... ... August 28, 2015 , ... As reported by Medical Daily on August ... for results that last for two years, the longest of any cellulite reduction system ... looking for a long-lasting, effective solution for their cellulite, according to Dr. Robert Weiss, ...
(Date:8/28/2015)... ... August 28, 2015 , ... On May 30th, 2015, ... as sponsor of the “Music With A Mission” benefit concert in Mendon, IL. Held ... was to raise money to support music education programs in the underfunded local school ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint ... grade protein with zero fat, carbs, sugar, gluten, lactose or caffeine in a ... for the 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods ...
(Date:8/28/2015)... ... August 28, 2015 , ... Altima Technologies, ... diagramming network and data center assets and audio-video devices, recently released Visio Stencils ... 5000 Series, HP ProLiant Gen9, EMC VNX Series , Super Micro Computer SuperStorage, ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3
... measuring how closely people follow dietary recommendations contained in tools ... been deveoped by researchers at the University of Alabama.//, According ... the children get older. ,The dual purposes of ... of a new measure of adherence to dietary recommendations and ...
... clothes treated with the common insecticide permethrin can reduce the ... study.// ,The conclusion was arrived at after Elizabeth Kimani ... and other researchers studied Somalian refugees living in camps in ... is 4.4 people, and only three percent of households have ...
... is still fresh in the memory. There are a whole ... adequate measure’ is considered extremely crucial.// It is better to ... in evolving suitable strategies against a potential Tsunami onslaught. , ... begin the exercise of delving into the seabed of Andaman ...
... was being treated for a bowel complaint, now faces the risk ... the hospital. // His left foot became infected when he was ... sent home, but returned four months later only to learn that ... the point of losing my leg. I feel really let down ...
... developed by Dr. Edward A. Hirschowitz and Dr. Li Zhong could ... at high risk for developing the disease. // Lung cancers ... around the world mainly because of the disease being diagnosed at ... is 49% higher than the national rate. However, the blood ...
... nitric oxide can significantly lower the risk of lung and ... but children must be studied for several years to assess ... , ,A clinical trial led by John Kinsella, MD, ... Children’s Hospital in Denver and a professor of pediatrics at ...
Cached Medicine News:Health News:Adherence to Dietary Recommendations Measured 2Health News:Adherence to Dietary Recommendations Measured 3Health News:New Blood Test For Early Detection Of Lung Cancer 2Health News:Early Nitric Oxide Treatment Can Help Low Birth Weight Preemies 2Health News:Early Nitric Oxide Treatment Can Help Low Birth Weight Preemies 3
10 L, Bulk Recommended for 2, 5 and 10 L pipettes....
10 L, Bulk Recommended for 5 & 10 L pipettes. Ideal for pipetting into long, narrow tubes or deep well plates....
This extended 10 ul combats contamination by keeping your pipettor out of 1.5 ul and 2.0 ul tubes. Utilizes MicroPoint design and 2 ul reference mark....
... The MonoPrep LBP Processor is a primary ... specimen collection, accessioning, processing, sampling, and slide ... data management. The MonoPrep LBP Processor produces ... from a broad range of cytology specimen ...
Medicine Products: